We are live on ! Find out more
GTF

CYTOMEDIX INC COM NEW
GTF

Delisted

GTF was delisted on the 25th of January, 2011.

2 hedge funds and large institutions have $19K invested in CYTOMEDIX INC COM NEW in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 12 (+1)

46% more capital invested

Capital invested by funds: $13K → $19K (+$6K)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
JIC
Joel Isaacson & Co
New York
+$5K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1
Edge Wealth Management
New York
$14K
JIC
2
Joel Isaacson & Co
New York
$5K +$5K +10,000 New

GTF Hedge Fund Activity: Q1 2014 in Review

2 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in CYTOMEDIX INC COM NEW (GTF) for Q1 2014, worth a combined $19K — up 46% from $13K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new GTF positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Joel Isaacson & Co, opening a new position worth an estimated $5K.

  • 2 institutional investors held CYTOMEDIX INC COM NEW (GTF) as of Q1 2014, up from 1 in Q4 2013.
  • Funds reported $19K of CYTOMEDIX INC COM NEW stock for Q1 2014, up 46% quarter-over-quarter.
  • 1 fund opened new CYTOMEDIX INC COM NEW positions in Q1 2014 and 0 closed out, a net change of +1 holder.
  • The largest CYTOMEDIX INC COM NEW buyer in Q1 2014 was Joel Isaacson & Co, an estimated $5K added.

Based on aggregated 13F filings for Q1 2014.